Infectious Disease Point of Care Diagnostics Market: By Product Type (Infectious Disease Testing Kits & Reagents, Haematology Testing Kits, Urinalysis Testing Kits, Others), By Disease Condition (Bacterial Infections, Fungal Infections, Viral Infections, Cardiovascular Infections, GI Infections, Sexually Transmitted Disease, CNS Infections, Other), By Prescription Mode (Over-The-Counter (OTC) Testing Kits, Prescription-based Testing Kits), By End User (Professional Diagnostic Centres, Homecare, Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Infectious Disease Point Of Care Diagnostics Market size was valued at USD 2,547.8 million in 2022 and is poised to grow at a significant CAGR of 7.2% from 2023-2029 Moreover, the technological advancements in point-of-care diagnostic devices and introduction of home-based point-of-care devices are also anticipated to boost the infectious disease point of care diagnostics market. However, reluctance among patients to change existing diagnostic practices, stringent regulatory policies, and reimbursement issues might restrain the growth of the global infectious disease point-of-care diagnostics market over the forecast timeframe. Point of care diagnostics refers to the tests carried out at the site of the patient care to provide immediate results. These diagnostics improve disease management and detection. Infectious diseases are caused by various microorganisms such as viruses, bacteria, fungi, and parasites. Infectious disease point-of-care diagnostics reduces the time between disease testing and diagnosis of an infection.

Nowadays most infectious diseases such as HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections are diagnosed by point-of-care testing. The major advantages with the point of point-of-care testing are reduced diagnosis time, postoperative care time, improvement in disease outcomes, accuracy in results, and simple methods for diagnosis of infectious diseases. The global infectious disease point-of-care diagnostics market is in the flourishing stage as several local and international players are actively involved in the development of infectious disease point-of-care diagnostic devices. An increase in the prevalence of the deadly infectious disease will drive the growth of the global infectious disease point-of-care diagnostics market. For instance, according to World Health Organisation, global health observatory (GHO) data, in 2013, approximately 34-38 million people suffered from HIV infection worldwide. Launching of new products, approvals from various regulatory bodies, acquisitions and mergers, partnerships, collaborations, and joint ventures are expected to fuel the growth of the global infectious disease point-of-care diagnostics market over the forecast period. For instance,

Infectious Disease Point Of Care Diagnostics Market Key Developments: 

  • In January 2015, the FDA approved Alere for its first CLIA waiver for the nucleic acid-based test, Influenza A&B. Further Roches CLIA waiver for Cobas Liat System and Strep A. By 2016, many systems received CLIA waivers from FDA including the Xpert Flu/RSV Xc by Cepheids.
  • In 2014, in the cardiovascular space, Spartan Biosciences had received approval from Health Care Canada for its genetic test, Spartan RX CYP2C19 system.
  • In 2014, Roche bought point-of-care molecular testing company iQuum for USD 275 million and the potential for an additional USD175 million in milestone payments  
 

Global Infectious Disease Point Of Care Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.2%

Largest Market

North America

Fastest Growing Market

Europe
Infectious Disease Point of Care Diagnostics Market Dynamics

Increase in the incidence and prevalence of infectious diseases such as malaria, dengue, HIV, rise in healthcare expenditure, growing investments from public and private sectors for the development of new products, rising government support towards the adoption of point of care devices are expected to drive global infectious disease point of care diagnostics market over the forecast period.

Global Infectious Disease Point Of Care Diagnostics Market Segmentation

By Product Type
  • Haematology Testing Kits
  • Urinalysis Testing Kits
  • Others
By Disease Condition
  • Bacterial Infections
  • Fungal Infections
  • Viral Infections
  • Cardiovascular Infections
  • GI Infections
  • Sexually Transmitted Disease
  • CNS Infections
  • Other
By Prescription Mode
  • Over-The-Counter (OTC) Testing Kits
  • Prescription-based Testing Kits
  • Based on end-user
  • Professional Diagnostic Centres
  • Homecare
  • Others

Frequently Asked Questions

The infectious disease point of care diagnostics market size was valued at USD x million in 2022

The infectious disease point of care diagnostics market key players are: Cepheid Inc. (Danaher Corporation) (U.S.) Abbott Laboratories, Inc. (U.S.) F. Hoffmann La Roche Limited (Switzerland) Beckman Coulter, Inc. (U.S.) Siemens Healthcare GmbH (Germany) Johnson & Johnson Services, Inc. (U.S.) Instrumentation Laboratory (U.S.) Becton, Dickinson and Company (U.S.) Alere Inc. (U.S.) Nova Biomedical (U.S.) Thermo Fisher Scientific (U.S.) Quidel Corporation (U.S.)

The infectious disease point of care diagnostics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  1. Executive summary
  2. Global Infectious Disease Point of Care Diagnostics Market Introduction
    • Global Infectious Disease Point of Care Diagnostics Market Taxonomy
    • Global Infectious Disease Point of Care Diagnostics Market Definitions
      • End User
      • Product Type
  1. Global Infectious Disease Point of Care Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Infectious Disease Point of Care Diagnostics Market Dynamics Factors Impact Analysis
    • Global Infectious Disease Point of Care Diagnostics Market Recent Product Launches
  2. Global Infectious Disease Point of Care Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Oppurtunity Analysis
  3. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029
    • Infectious Disease Testing Kits & Reagents
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Haematology Testing Kits
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Urinalysis Testing Kits
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Disease Condition, 2018 - 2022 and Forecast, 2023 - 2029
    • Bacterial Infections
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Fungal Infections
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Viral Infections
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cardiovascular Infections
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • GI Infections
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Sexually Transmitted Disease
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CNS Infections
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Prescription Mode, 2018 - 2022 and Forecast, 2023 - 2029
    • Over-the-counter (OTC) Testing Kits
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prescription-based Testing Kits
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Infectious Disease Point of Care Diagnostics Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
    • Professional Diagnostic Centers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Homecare
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Infectious Disease Point of Care Diagnostics Market- Opportunity Analysis Index - By Product Type, By Disease Condition, By Prescription Mode, By End User, and Region, 2023 - 2029
  2. North America Infectious Disease Point of Care Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Infectious Disease Testing Kits & Reagents
        • Hepatitis
        • HIV Infection
        • Respiratory Infections
        • Influenza
        • Sexually-Transmitted Diseases (STDs)
        • Others
      • Haematology Testing Kits
      • Urinalysis Testing Kits
      • Others
    • Disease Condition Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Bacterial Infections
      • Fungal Infections
      • Viral Infections
      • Cardiovascular Infections
      • GI Infections
      • Sexually Transmitted Disease
      • CNS Infections
      • Other
    • Prescription Mode Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Over-The-Counter (OTC) Testing Kits
      • Prescription-based Testing Kits
    • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Professional Diagnostic Centres
        • Hospitals
        • Outpatient Healthcare Setting
      • Homecare
      • Others
    • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Infectious Disease Point of Care Diagnostics Market- Opportunity Analysis Index - By Product Type, By Disease Condition, By Prescription Mode, By End User, and Country, 2023 - 2029
    • North America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
  3. Europe Infectious Disease Point of Care Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Infectious Disease Testing Kits & Reagents
        • Hepatitis
        • HIV Infection
        • Respiratory Infections
        • Influenza
        • Sexually-Transmitted Diseases (STDs)
        • Others
      • Haematology Testing Kits
      • Urinalysis Testing Kits
      • Others
    • Disease Condition Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Bacterial Infections
      • Fungal Infections
      • Viral Infections
      • Cardiovascular Infections
      • GI Infections
      • Sexually Transmitted Disease
      • CNS Infections
      • Other
    • Prescription Mode Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Over-The-Counter (OTC) Testing Kits
      • Prescription-based Testing Kits
    • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Professional Diagnostic Centres
        • Hospitals
        • Outpatient Healthcare Setting
      • Homecare
      • Others
    • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Infectious Disease Point of Care Diagnostics Market- Opportunity Analysis Index - By Product Type, By Disease Condition, By Prescription Mode, By End User, and Country, 2023 - 2029
    • Europe Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
  4. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Infectious Disease Testing Kits & Reagents
        • Hepatitis
        • HIV Infection
        • Respiratory Infections
        • Influenza
        • Sexually-Transmitted Diseases (STDs)
        • Others
      • Haematology Testing Kits
      • Urinalysis Testing Kits
      • Others
    • Disease Condition Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Bacterial Infections
      • Fungal Infections
      • Viral Infections
      • Cardiovascular Infections
      • GI Infections
      • Sexually Transmitted Disease
      • CNS Infections
      • Other
    • Prescription Mode Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Over-The-Counter (OTC) Testing Kits
      • Prescription-based Testing Kits
    • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Professional Diagnostic Centres
        • Hospitals
        • Outpatient Healthcare Setting
      • Homecare
      • Others
    • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn),
  5. Y-o-Y Growth (%), and Market Share (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Asia-Pacific Infectious Disease Point of Care Diagnostics Market- Opportunity Analysis Index - By Product Type, By Disease Condition, By Prescription Mode, By End User, and Country, 2023 - 2029
  • Asia-Pacific Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
  1. Latin America Infectious Disease Point of Care Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Infectious Disease Testing Kits & Reagents
        • Hepatitis
        • HIV Infection
        • Respiratory Infections
        • Influenza
        • Sexually-Transmitted Diseases (STDs)
        • Others
      • Haematology Testing Kits
      • Urinalysis Testing Kits
      • Others
    • Disease Condition Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Bacterial Infections
      • Fungal Infections
      • Viral Infections
      • Cardiovascular Infections
      • GI Infections
      • Sexually Transmitted Disease
      • CNS Infections
      • Other
    • Prescription Mode Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Over-The-Counter (OTC) Testing Kits
      • Prescription-based Testing Kits
    • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Professional Diagnostic Centres
        • Hospitals
        • Outpatient Healthcare Setting
      • Homecare
      • Others
    • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Infectious Disease Point of Care Diagnostics Market- Opportunity Analysis Index - By Product Type, By Disease Condition, By Prescription Mode, By End User, and Country, 2023 - 2029
    • Latin America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
  2. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Infectious Disease Testing Kits & Reagents
        • Hepatitis
        • HIV Infection
        • Respiratory Infections
        • Influenza
        • Sexually-Transmitted Diseases (STDs)
        • Others
      • Haematology Testing Kits
      • Urinalysis Testing Kits
      • Others
    • Disease Condition Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Bacterial Infections
      • Fungal Infections
      • Viral Infections
      • Cardiovascular Infections
      • GI Infections
      • Sexually Transmitted Disease
      • CNS Infections
      • Other
    • Prescription Mode Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Over-The-Counter (OTC) Testing Kits
      • Prescription-based Testing Kits
    • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Professional Diagnostic Centres
        • Hospitals
        • Outpatient Healthcare Setting
      • Homecare
      • Others
    • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Infectious Disease Point of Care Diagnostics Market- Opportunity Analysis Index - By Product Type, By Disease Condition, By Prescription Mode, By End User, and Country, 2023 - 2029
    • MEA Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
  3. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Cepheid Inc. (Danaher Corporation) (U.S.)
      • Abbott Laboratories, Inc. (U.S.)
      • Hoffmann La Roche Limited (Switzerland)
      • Beckman Coulter, Inc. (U.S.)
      • Siemens AG (Germany)
      • Johnson & Johnson Services, Inc. (U.S.)
      • Instrumentation Laboratory (U.S.)
      • Becton, Dickinson and Company (U.S.)
      • Alere Inc. (U.S.)
      • Nova Biomedical (U.S.)
      • Thermo Fisher Scientific Inc. (U.S.)
      • Quidel Corporation (U.S.)
  4. Research Methodology
  5. Key Assumptions and Acronyms
  • Cepheid Inc. (Danaher Corporation) (U.S.)
  • Abbott Laboratories, Inc. (U.S.)
  • F. Hoffmann La Roche Limited (Switzerland)
  • Beckman Coulter, Inc. (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Instrumentation Laboratory (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Alere Inc. (U.S.)
  • Nova Biomedical (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Quidel Corporation (U.S.)

Adjacent Markets